WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CRSP past revenue growth

How has CRSP's revenue growth performed historically?
Company
18.89%
Industry
76.88%
Market
16.68%
CRSP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CRSP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CRSP's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CRSP earnings and revenue history

Current Revenue
$202.2M
Current Earnings
-$265.8M
Current Profit Margin
-131.4%

CRSP Return on Equity

Current Company
-13.9%
Current Industry
23.1%
Current Market
34.1%
CRSP's Return on Equity (-13.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CRSP announces earnings.

CRSP Return on Assets

Current Company
-11.7%
Current Industry
3.6%
CRSP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CRSP Return on Capital Employed

Current Company
-11.9%
Current Industry
21.5%
CRSP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRSP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CRSP$202.23M-$243.65M-$265.80M+173.39%N/A
ADMA$330.24M$67.70M$34.79M+78.20%N/A
ACLX$144.75M-$24.88M-$53.89M+349.32%N/A
DNLI$1.27M-$411.13M-$419.65M-60.71%N/A
CORT$569.61M$128.08M$124.95M+16.24%+12.40%
View Top Biotech Stocks

CRSP earnings dates

Next earnings date
Nov 4, 2024

Crispr Therapeutics Ag Earnings & Revenue FAQ

What were CRSP's earnings last quarter?

Crispr Therapeutics Ag (NASDAQ: CRSP) reported Q2 2024 earnings per share (EPS) of -$1.49, up 52.04% year over year. Total Crispr Therapeutics Ag earnings for the quarter were -$126.41 million. In the same quarter last year, Crispr Therapeutics Ag's earnings per share (EPS) was -$0.98.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.

What was CRSP's earnings growth in the past year?

As of Q3 2024, Crispr Therapeutics Ag's earnings has grown year over year. Crispr Therapeutics Ag's earnings in the past year totalled -$265.80 million.

What is CRSP's earnings date?

Crispr Therapeutics Ag's earnings date is Invalid Date. Add CRSP to your watchlist to be reminded of CRSP's next earnings announcement.

What was CRSP's revenue last quarter?

Crispr Therapeutics Ag (NASDAQ: CRSP) reported Q2 2024 revenue of $517.00 thousand up 99.26% year over year. In the same quarter last year, Crispr Therapeutics Ag's revenue was $70.00 million.

What was CRSP's revenue growth in the past year?

As of Q3 2024, Crispr Therapeutics Ag's revenue has grown 18.89% year over year. This is 58 percentage points lower than the US Biotechnology industry revenue growth rate of 76.88%. Crispr Therapeutics Ag's revenue in the past year totalled $202.23 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.